about
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding siteTNF-α blocker effect of naringenin-loaded sericin microparticles that are potentially useful in the treatment of psoriasis.Novel Enantiopure Sigma Receptor Modulators: Quick (Semi-)Preparative Chiral Resolution via HPLC and Absolute Configuration Assignment.Enantioselective Modulatory Effects of Naringenin Enantiomers on the Expression Levels of miR-17-3p Involved in Endogenous Antioxidant Defenses.PKC in Regenerative Therapy: New Insights for Old Targets.Sigma receptor modulators: a patent review.The C1 domain-targeted isophthalate derivative HMI-1b11 promotes neurite outgrowth and GAP-43 expression through PKCα activation in SH-SY5Y cells.Discovery of small peptides derived from embryonic lethal abnormal vision proteins structure showing RNA-stabilizing properties.An eco-friendly enantioselective access to (R)-naringenin as inhibitor of proinflammatory cytokine release.Studies on the enantiomers of RC-33 as neuroprotective agents: isolation, configurational assignment, and preliminary biological profile.Enantiomers of 2-[(Acylamino)ethyl]-1,4-benzodiazepines, potent ligands of kappa-opioid receptor: chiral chromatographic resolution, configurational assignment and biological activity.Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities.Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.Marrubium vulgare L. Leave Extract: Phytochemical Composition, Antioxidant and Wound Healing Properties.Design, synthesis, and SAR analysis of novel selective sigma1 ligands.Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2).Influence of the extraction mode on the yield of hyperoside, vitexin and vitexin-2''-O-rhamnoside from Crataegus monogyna Jacq. (hawthorn).Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines.Substituted benzylaminoalkylindoles with preference for the sigma2 binding site.Regulation of Aquaporin Functional Properties Mediated by the Antioxidant Effects of Natural Compounds.Compounds Interfering with Embryonic Lethal Abnormal Vision (ELAV) Protein-RNA Complexes: An Avenue for Discovering New Drugs.Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-2.Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.Microwave-assisted extraction of coumarin and related compounds from Melilotus officinalis (L.) Pallas as an alternative to Soxhlet and ultrasound-assisted extraction.Quantitative structure-activity relationship modeling of growth hormone secretagogues agonist activity of some tetrahydroisoquinoline 1-carboxamides.Proteometric study of ghrelin receptor function variations upon mutations using amino acid sequence autocorrelation vectors and genetic algorithm-based least square support vector machines.PEG 400/Cerium Ammonium Nitrate Combined with Microwave-Assisted Synthesis for Rapid Access to Beta-Amino Ketones. An Easy-to-Use Protocol for Discovering New Hit Compounds.Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands.Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes.A Versatile Strategy for the Synthesis of 4,5-Dihydroxy-2,3-Pentanedione (DPD) and Related Compounds as Potential Modulators of Bacterial Quorum SensingExploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approachStudies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A adenosine receptorIdentification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-Scale synthesis, physicochemical characterization and in vitro metabolic stabilityBreakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes⁻4Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer AgentsDevelopment of a Mucoadhesive and an in Situ Gelling Formulation Based on κ-Carrageenan for Application on Oral Mucosa and Esophagus Walls. II. Loading of a Bioactive Hydroalcoholic ExtractAn efficient procedure based on a MW-assisted Horner-Wadsworth-Emmons reaction for the synthesis of (Z)-3,3-trisubstituted-alpha,beta-unsaturated esters.Synthesis and antinociceptive activity of pyrrolidinylnaphthalenesSynthesis of pyrrolinylnaphthalenes and evaluation of their antinociceptive activity
P50
Q28277939-030A6A3C-FA2E-40A4-9D9A-F4BD9717A3B4Q35220914-FDD42686-4E5F-4176-AD60-5514B0F614F6Q36132213-B3AA452E-8566-44B3-B91C-1F4AE6803AFCQ36298636-1F294B60-E80F-48AF-9E86-F1AB0AB096D3Q36376317-2E6C72F0-36F6-43D1-B25B-A89017206138Q38079638-DB55AAC2-0D64-4A0C-86A1-0D1B3B75DCEBQ39156422-B50A8985-102B-4002-B477-1F5539EB868CQ39818540-F4289168-5DB2-461B-BC52-64F45E3FA4CBQ43686167-A944706C-B16C-4AF0-BF7C-7A466C721F88Q43695245-A6A6CDAD-3BDE-45F6-B463-5F1E5C2E5F73Q43752626-FD54F06D-6BF8-40DB-93E8-B5AAA8745137Q43869153-160BEEF6-B429-4628-9717-B759BC2872FDQ44342617-FA8D1AC9-0A7B-40ED-A81F-1A2C24109FD7Q46260489-90518084-5DED-4B70-B126-7B9FFB471A76Q46391370-50BC00B4-B288-4433-B96C-DB22FA46FED4Q46450912-261E3273-FE19-4026-B5F9-58DF9B12FFE5Q46489771-3D7E6C74-B6A7-44A9-8930-D2AF5B63E1B9Q46704655-FACFE0BE-B69D-42B2-B427-9A41004CB4B5Q46858454-8AE5909B-8B4E-4B19-B509-529F17010A06Q47239441-4135C179-8873-47C4-A39D-792AA88B4027Q48319738-F2118D49-BD64-4C4A-BD49-863AFE47E77EQ48337589-A6F4AAFB-78D0-4F67-A14D-F505660958BEQ48923483-43A77DB2-2DC2-4EE1-92FA-3ABDF09C0D6BQ51725718-0215ACEA-A576-4F74-B0C2-CA2BDDC161ACQ51921868-4537AA44-6FDA-4DDC-A162-28350E0F1D63Q51925071-FC13DE76-2E28-4814-B91D-F004E67B4CCDQ52621415-B148F55E-D58E-4363-85BD-2F430169DCA1Q52623208-477C557C-59C5-409A-B66D-E1FA2CCDFFF8Q53731615-AA90B1CF-525E-4210-93A0-0B1056C58723Q57297095-53D439BE-93A6-4BB0-BCB6-C4BF62D13BC1Q58743732-1C657597-4123-4261-8C15-B4DA968A02E3Q58856016-DCAF4B4D-0893-40B8-9D01-9AAD67EEC113Q60587911-6EE545F5-AFF5-4FE2-BBF9-4E1B558E89A2Q61453558-41DFDBB3-36AE-47C8-8C4E-07C9DE7C1B7AQ62470829-7BBE8564-ED13-4B8C-9C6E-251F5C560824Q64062976-CDCB584A-B4C0-48BD-8884-866A19A228CCQ64063850-3534FA74-CC40-4D41-A9A6-CF279B229945Q64905680-02F70937-120D-4D77-B01C-1631460AB680Q72995215-5786A4C4-9778-4AD5-89A7-8846B04ECBD7Q73383590-62F7D8BE-3B02-4493-B8F0-66ECCAA250A1
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Simona Collina
@ast
Simona Collina
@en
Simona Collina
@es
Simona Collina
@nl
type
label
Simona Collina
@ast
Simona Collina
@en
Simona Collina
@es
Simona Collina
@nl
altLabel
SIMONA COLLINA
@en
prefLabel
Simona Collina
@ast
Simona Collina
@en
Simona Collina
@es
Simona Collina
@nl
P106
P1153
6701762619
P21
P2798
P31
P496
0000-0002-2954-7558